Eva M. Noorda

474 total citations
11 papers, 244 citations indexed

About

Eva M. Noorda is a scholar working on Oncology, Biomedical Engineering and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Eva M. Noorda has authored 11 papers receiving a total of 244 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Biomedical Engineering and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Eva M. Noorda's work include Cutaneous Melanoma Detection and Management (8 papers), CAR-T cell therapy research (4 papers) and Sarcoma Diagnosis and Treatment (3 papers). Eva M. Noorda is often cited by papers focused on Cutaneous Melanoma Detection and Management (8 papers), CAR-T cell therapy research (4 papers) and Sarcoma Diagnosis and Treatment (3 papers). Eva M. Noorda collaborates with scholars based in Netherlands and United States. Eva M. Noorda's co-authors include Omgo E. Nieweg, Bart C. Vrouenraets, Bin B. R. Kroon, Gooike W. van Slooten, Frits van Coevorden, Bert N. van Geel, Alexander M.M. Eggermont, Guus Hart, R. Bart Takkenberg and Anne Brecht Francken and has published in prestigious journals such as Cancer, Annals of Surgical Oncology and Journal of Surgical Oncology.

In The Last Decade

Eva M. Noorda

10 papers receiving 240 citations

Peers

Countries citing papers authored by Eva M. Noorda

Since Specialization

Citations

This map shows the geographic impact of Eva M. Noorda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva M. Noorda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva M. Noorda more than expected).

Fields of papers citing papers by Eva M. Noorda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva M. Noorda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva M. Noorda. The network helps show where Eva M. Noorda may publish in the future.

Co-authorship network of co-authors of Eva M. Noorda

This figure shows the co-authorship network connecting the top 25 collaborators of Eva M. Noorda. A scholar is included among the top collaborators of Eva M. Noorda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva M. Noorda. Eva M. Noorda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Implementation of the Targeted Axillary Dissection Procedure in Clinically Node-Positive Breast Cancer: A Retrospective Analysis 2024 ·Annals of Surgical Oncology ·(unknown), (unknown), (unknown), Eva M. Noorda, (unknown), (unknown), (unknown), (unknown), (unknown), Anne Brecht Francken	7
2	Radioactive seed localization is the preferred technique in nonpalpable breast cancer compared with wire-guided localization and radioguided occult lesion localization 2017 ·Nuclear Medicine Communications ·(unknown), (unknown), Mireille A. Edens, (unknown), (unknown), Piet L. Jager, Eva M. Noorda, Anne Brecht Francken	14
3	Isolated Limb Perfusion for Melanoma 2008 ·Surgical Oncology Clinics of North America ·Bin B. R. Kroon, Eva M. Noorda, Bart C. Vrouenraets, Gooike W. van Slooten, Omgo E. Nieweg	35
4	Isolated Limb Perfusion in Regional Melanoma 2006 ·Surgical Oncology Clinics of North America ·Eva M. Noorda, Bart C. Vrouenraets, Omgo E. Nieweg, Bin B. R. Kroon	4
5	Isolated Limb Perfusion Prolongs the Limb Recurrence-Free Interval After Several Episodes of Excisional Surgery for Locoregional Recurrent Melanoma 2004 ·Annals of Surgical Oncology ·Eva M. Noorda, R. Bart Takkenberg, Bart C. Vrouenraets, Omgo E. Nieweg, Bert N. van Geel, Alexander M.M. Eggermont, Guus Hart, Bin B. R. Kroon	22
6	Isolated Limb Perfusion: What Is the Evidence for Its Use? 2004 ·Annals of Surgical Oncology ·Eva M. Noorda, Bart C. Vrouenraets, Omgo E. Nieweg, Frits van Coevorden, Bin B. R. Kroon	21
7	Isolated Limb Perfusion for Unresectable Melanoma of the Extremities 2004 ·Archives of Surgery ·Eva M. Noorda	52
8	Indications and Results of Isolated Limb Perfusion 2004 ·Amsterdam University Press eBooks ·Eva M. Noorda	0
9	Long-term results of a double perfusion schedule using high dose hyperthermia and melphalan sequentially in extensive melanoma of the lower limb 2003 ·Melanoma Research ·Eva M. Noorda, Bart C. Vrouenraets, Omgo E. Nieweg, Joost M. Klaase, (unknown), (unknown)	14
10	Isolated limb perfusion with tumor necrosis factor‐α and melphalan for patients with unresectable soft tissue sarcoma of the extremities 2003 ·Cancer ·Eva M. Noorda, Bart C. Vrouenraets, Omgo E. Nieweg, Frits van Coevorden, Gooike W. van Slooten, Bin B. R. Kroon	65
11	Isolated limb perfusion for melanoma 2002 ·Journal of Surgical Oncology ·Bin B. R. Kroon, Eva M. Noorda, Bart C. Vrouenraets, Omgo E. Nieweg	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact